Control of brain metastases with alectinib in anaplastic lymphoma kinase‐rearranged lung cancer

Brain metastasis from non‐small cell lung cancer remains a challenge to physicians. It occurs in 30% of patients with advanced stage adenocarcinoma of lung and is often regarded as the ominous sign of disease progression and death. Alectinib is likely to be a promising agent, even after the failure...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwok, Wang Chun, Tam, Terence Chi Chun, Lui, Macy Mei Sze, Lam, David Chi Leung, Ho, James Chung Man
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2017
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338141/
https://www.ncbi.nlm.nih.gov/pubmed/28275428
http://dx.doi.org/10.1002/rcr2.224

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338141/
https://www.ncbi.nlm.nih.gov/pubmed/28275428
http://dx.doi.org/10.1002/rcr2.224

Ejemplares similares